Article Text

PDF
VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity
  1. C Pieh1,
  2. H Agostini1,
  3. C Buschbeck1,
  4. M Krüger2,
  5. J Schulte-Mönting3,
  6. U Zirrgiebel4,
  7. J Drevs5,
  8. W A Lagrèze1
  1. 1
    Department of Ophthalmology, University Hospital Freiburg, Freiburg, Germany
  2. 2
    Department of Pediatrics, University Hospital Freiburg, Freiburg, Germany
  3. 3
    Department of Medical Biometry and Statistics, University of Freiburg, Freiburg, Germany
  4. 4
    ProQinase GmbH, Clinical Biomarker Analysis, Freiburg, Germany
  5. 5
    Department of Cancer Biology, University of Freiburg, Freiburg, Germany
  1. Dr C Pieh, Universitäts-Augenklinik, Freiburg, Killianstrasse 5, 79106 Freiburg, Germany; christina.pieh{at}uniklinik-freiburg.de

Abstract

Aim: To study prospectively the plasma levels of vascular endothelial growth factor (VEGF-A), its soluble receptors sVEGFR-1, sVEGFR-2 and soluble Tie2 in premature infants. To identify their changes related to the onset of retinopathy of prematurity (ROP).

Methods: Blood samples of 63 preterm infants born at a postmenstrual age (PMA) of 23–32 weeks were obtained between 5 days and 15 weeks after birth. 42 infants had no ROP, two had stage 1, nine stage 2 and 10 stage 3. Of these, four infants were treated with retinal photocoagulation. VEGF-A, sVEGFR-1, sVEGFR-2, and sTie2 were measured in the plasma with a sandwich enzyme immunoassay using factor-specific monoclonal mouse antibodies. The time course of concentrations plotted by kernel smoothing in infants with and without ROP were compared and a paired subgroup with analysis of variance was analysed.

Results: ROP patients had raised plasma levels of sVEGFR-2 and sTie2 compared with premature infants without ROP. VEGF-A and sVEGFR-1 levels were similar in both groups. Analysis of a subgroup with pairs of measurements, one before 32 weeks and one after 36 weeks, showed a significant increase in sTie2 after 36 weeks of PMA independent of ROP (p = 0.03).

Conclusion: This is the first study to measure plasma levels of angiogenic factors in ROP. Similar VEGF-A plasma levels in infants with and without ROP suggest that pathogenic retinal angiogenesis in ROP is mainly driven by local VEGF-A synthesis. Elevated plasma levels in active ROP were observed for sVEGFR-2 and sTie2. These increases have yet to be confirmed as predictive values for ROP.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None declared.

  • Ethics approval: This study adhered to the tenets of the Declaration of Helsinki and was approved by the Ethics Committee of the Albert-Ludwigs-University Freiburg, Germany.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.